Topic

Barron's

A collection of 2 issues

Moderna Surges as Barron's Declares It 'Too Cheap'

Moderna stock skyrockets in the S&P 500 after Barron's highlights it as 'too cheap' and a top 10 pick for 2025. Discover why investors are watching closely.

Moderna Soars as Barron's Highlights Its Value

Moderna stock skyrockets, leading the S&P 500 after Barron's names it a top 2025 pick, citing it as 'too cheap' to ignore. Discover why it's a must-watch.